#scleroderma kết quả tìm kiếm

2024 @RheumatologyUK guideline for management of systemic sclerosis #scleroderma Early diagnosis ▶️History: #Raynaud’s phenomenon ▶️Examination: Puffy fingers ▶️Investigation: ANA, nailfold #capillaroscopy, SSc-specific autoantibodies 👉🏽academic.oup.com/rheumatology/a… via @RheumJnl

DrAiLynTan's tweet image. 2024 @RheumatologyUK guideline for management of systemic sclerosis #scleroderma

Early diagnosis
▶️History: #Raynaud’s phenomenon
▶️Examination: Puffy fingers
▶️Investigation: ANA, nailfold #capillaroscopy, SSc-specific autoantibodies

👉🏽academic.oup.com/rheumatology/a…
via @RheumJnl

#Scleroderma specific autoantibodies in predicting prognosis/survival ➡️ almost all #ANA positive 📈 Best survival in anticentromere group 📉 Diffuse subtype carries a worse prognosis especially Anti-Scl70, anti-RNA polymerase III & If 🫁 ILD present [AL Herrick]

LastManStand85's tweet image. #Scleroderma specific autoantibodies in predicting prognosis/survival 

➡️ almost all #ANA positive

📈 Best survival in anticentromere group
 
📉 Diffuse subtype carries a worse prognosis especially Anti-Scl70, anti-RNA polymerase III & If 🫁 ILD present 

[AL Herrick]

🧵1/ 👁 Ever wanted to see autoimmune Microvascular dysfunction in action? Nailfold Videocapillaroscopy (NVC) gives us a live look into systemic vascular health. A powerful, non-invasive window for early diagnosis in CTDs. Let’s walk through what it reveals in #Scleroderma.…

IlliasulK's tweet image. 🧵1/
👁 Ever wanted to see autoimmune Microvascular dysfunction in action?

Nailfold Videocapillaroscopy (NVC) gives us a live look into systemic vascular health. A powerful, non-invasive window for early diagnosis in CTDs.

Let’s walk through what it reveals in #Scleroderma.…

The 3rd #Scleroderma_preceptorship_program The journey of enhancing and optimizing the care of #Scleroderma patients in Saudi Arabia continues to show more promise 💐 Big thanks to: Patients, attendees, speakers and chairpersons @ssrsa_org for facilitating @Boehringer

WaleedHafiz786's tweet image. The 3rd #Scleroderma_preceptorship_program 

The journey of enhancing and optimizing the care of #Scleroderma patients in Saudi Arabia continues to show more promise 💐

Big thanks to: 
Patients, attendees, speakers and chairpersons

@ssrsa_org for facilitating 
@Boehringer…
WaleedHafiz786's tweet image. The 3rd #Scleroderma_preceptorship_program 

The journey of enhancing and optimizing the care of #Scleroderma patients in Saudi Arabia continues to show more promise 💐

Big thanks to: 
Patients, attendees, speakers and chairpersons

@ssrsa_org for facilitating 
@Boehringer…
WaleedHafiz786's tweet image. The 3rd #Scleroderma_preceptorship_program 

The journey of enhancing and optimizing the care of #Scleroderma patients in Saudi Arabia continues to show more promise 💐

Big thanks to: 
Patients, attendees, speakers and chairpersons

@ssrsa_org for facilitating 
@Boehringer…
WaleedHafiz786's tweet image. The 3rd #Scleroderma_preceptorship_program 

The journey of enhancing and optimizing the care of #Scleroderma patients in Saudi Arabia continues to show more promise 💐

Big thanks to: 
Patients, attendees, speakers and chairpersons

@ssrsa_org for facilitating 
@Boehringer…

Systemic Sclerosis–Associated ILD Watch Alicia Hinze, MD, share personalized strategies for managing Systemic Sclerosis–Associated ILD. Sponsored By: Boehringer Ingelheim buff.ly/w9qmEr7 #ILD #Scleroderma

RheumNow's tweet image. Systemic Sclerosis–Associated ILD

Watch Alicia Hinze, MD, share personalized strategies for managing Systemic Sclerosis–Associated ILD. Sponsored By: Boehringer Ingelheim 

buff.ly/w9qmEr7 

#ILD #Scleroderma

Hey everyone! Today is #WorldSclerodermaDay I’m raising awareness about this debilitating disease! I’m in my 4th year. Don’t give up hope! We will find a cure. I’m happy to be thriving. Thanks for the love! ❤️🙏🏼#scleroderma

ClaireDeVille3's tweet image. Hey everyone! Today is #WorldSclerodermaDay I’m raising awareness about this debilitating disease! I’m in my 4th year. Don’t give up hope! We will find a cure. I’m happy to be thriving. Thanks for the love! ❤️🙏🏼#scleroderma

🧵 Skin Manifestations of Systemic Sclerosis (SSc) The skin is often the first—and most revealing—organ affected. Here’s a layered look at what to watch for 👇 #Rheumatology #Scleroderma #MedTwitter @IhabFathiSulima @Janetbirdope @DrAkhilX @Drkhenaizan @MattersRheum

Rheumat_Aravind's tweet image. 🧵 Skin Manifestations of Systemic Sclerosis (SSc)
The skin is often the first—and most revealing—organ affected. Here’s a layered look at what to watch for 👇
#Rheumatology #Scleroderma #MedTwitter @IhabFathiSulima @Janetbirdope @DrAkhilX @Drkhenaizan @MattersRheum

Hope for people. Living with #scleroderma but ?too many #trials Difficult to recruit! gaps 👇 need to study lcSSc, longer disease duration ?prevention in ⬆️risk #VEDOSS Dr Dinesh Khanna presents LOADs of #trials #FSR2025 @FloridaRheums @RheumNow @sclerodermaUM

Janetbirdope's tweet image. Hope for people. Living with
#scleroderma 

but 
?too many #trials

Difficult to recruit!

gaps
👇
need to study lcSSc, 
longer disease duration 
?prevention in ⬆️risk #VEDOSS

Dr Dinesh Khanna presents LOADs of #trials 

#FSR2025 @FloridaRheums @RheumNow  @sclerodermaUM

Late-onset interstitial lung disease (ILD) in #scleroderma may be more common than we think. In our NEWEST episode, we discuss why #ILD can develop years after diagnosis & what this means for screening practices. 🎙️ LISTEN NOW → acr.tw/4mAoxJ6 @ACR_Journals

ACRheum's tweet image. Late-onset interstitial lung disease (ILD) in #scleroderma may be more common than we think. In our NEWEST episode, we discuss why #ILD can develop years after diagnosis & what this means for screening practices. 🎙️ LISTEN NOW → acr.tw/4mAoxJ6 @ACR_Journals

2 years ago,I was invited onto @BBCSheffield Paulette's show to talk about my #scleroderma I've kindly been invited back on to talk about allsorts this Wednesday morning! Wish me luck !!

sclerodermasara's tweet image. 2 years ago,I was invited onto @BBCSheffield Paulette's show to talk about my #scleroderma 
I've kindly been invited back on to talk about allsorts this Wednesday morning! Wish me luck !!

#scleroderma 1. why is SSc- a 'fibrotic disease' treated with immunosuppressive? 2. Why dont every patient with early SSc respond to immunosuppressive? the lessons lie in understanding the underlying mechanisms of early SSc and molecular heterogeneity. @IRACON24Blr

sclerodermaUM's tweet image. #scleroderma 
1. why is SSc- a 'fibrotic disease' treated with immunosuppressive?
2. Why dont every patient with early SSc respond to immunosuppressive? 
the lessons lie in understanding the underlying mechanisms of early SSc and molecular heterogeneity.  @IRACON24Blr
sclerodermaUM's tweet image. #scleroderma 
1. why is SSc- a 'fibrotic disease' treated with immunosuppressive?
2. Why dont every patient with early SSc respond to immunosuppressive? 
the lessons lie in understanding the underlying mechanisms of early SSc and molecular heterogeneity.  @IRACON24Blr

Scleroderma 101! What happens when your own body turns against you? Scleroderma is a relentless rare disease that goes far beyond the skin. #Scleroderma #RareDisease #CME @SclerodermaCO


Excited to present WIN #scleroderma #eular2025. This slide highlights the opportunities in drug development in SSc. Come and join on Saturday 6/14 at 9 AM CET.

sclerodermaUM's tweet image. Excited to present  WIN  #scleroderma #eular2025. This slide highlights the opportunities in drug development in  SSc. Come and join on Saturday 6/14 at 9 AM CET.

Excited to present data from RESET-SSc in #scleroderma #eular2025. CAR-T was well tolerated with beneficial effects on skin/ FVC. Exciting data on U-M IIS with LN bx showing complete depletion of B cells at 3 weeks and NFC showing normalization of capillary density and size

sclerodermaUM's tweet image. Excited to present data from RESET-SSc in #scleroderma #eular2025. CAR-T was well tolerated with beneficial effects on skin/ FVC. Exciting data on U-M IIS with LN bx showing complete depletion of B cells at 3 weeks and NFC showing normalization of capillary density and size
sclerodermaUM's tweet image. Excited to present data from RESET-SSc in #scleroderma #eular2025. CAR-T was well tolerated with beneficial effects on skin/ FVC. Exciting data on U-M IIS with LN bx showing complete depletion of B cells at 3 weeks and NFC showing normalization of capillary density and size
sclerodermaUM's tweet image. Excited to present data from RESET-SSc in #scleroderma #eular2025. CAR-T was well tolerated with beneficial effects on skin/ FVC. Exciting data on U-M IIS with LN bx showing complete depletion of B cells at 3 weeks and NFC showing normalization of capillary density and size
sclerodermaUM's tweet image. Excited to present data from RESET-SSc in #scleroderma #eular2025. CAR-T was well tolerated with beneficial effects on skin/ FVC. Exciting data on U-M IIS with LN bx showing complete depletion of B cells at 3 weeks and NFC showing normalization of capillary density and size

Delighted to present the @bmsnews data on #scleroderma #eular2025. Breakfree-1 data showing CAR-T is well tolerated with beneficial effects on skin and FVC and composite endpoint, the revised CRISS.

sclerodermaUM's tweet image. Delighted to present the @bmsnews data on #scleroderma #eular2025. Breakfree-1 data showing CAR-T is well tolerated with beneficial effects on skin and FVC and composite endpoint, the revised CRISS.
sclerodermaUM's tweet image. Delighted to present the @bmsnews data on #scleroderma #eular2025. Breakfree-1 data showing CAR-T is well tolerated with beneficial effects on skin and FVC and composite endpoint, the revised CRISS.
sclerodermaUM's tweet image. Delighted to present the @bmsnews data on #scleroderma #eular2025. Breakfree-1 data showing CAR-T is well tolerated with beneficial effects on skin and FVC and composite endpoint, the revised CRISS.

🎊 Congratulations to Dr @Huda_Alfaris on the successful completion of the @UofTRheum #Scleroderma Fellowship! @SchroederInst @UHN_Research @SclerodermaCAN @CSRG2022

SindhuJohnson5's tweet image. 🎊 Congratulations to Dr @Huda_Alfaris on the successful completion of the @UofTRheum #Scleroderma Fellowship! @SchroederInst @UHN_Research @SclerodermaCAN @CSRG2022

Join expert rheumatologists from @NorthwesternMed for the Scleroderma Educational Event on October 24. This event will explore the latest developments in #scleroderma research and management from a multidisciplinary perspective. Learn more and register now:…


New data suggest #ILD can develop well beyond the early years of #scleroderma. Drs. Marie Hudson & Sabrina Hoa talk about their findings, clinical implications, & why trial criteria may need to change. LISTEN NOW → acr.tw/4mAoxJ6 @ACR_Journals

ACRheum's tweet image. New data suggest #ILD can develop well beyond the early years of #scleroderma. Drs. Marie Hudson & Sabrina Hoa talk about their findings, clinical implications, & why trial criteria may need to change. LISTEN NOW → acr.tw/4mAoxJ6 @ACR_Journals

Missed our latest Virtual Education Session? No worries - we’ve got you! Lawyer Ross Sottile from Maurice Blackburn explored the link between workplace exposure and #scleroderma. Read the full blog post here: sclerodermavictoria.com.au/scleroderma-an… #OccupationalScleroderma

scleroderma_vic's tweet image. Missed our latest Virtual Education Session? No worries - we’ve got you!

Lawyer Ross Sottile from Maurice Blackburn explored the link between workplace exposure and #scleroderma.

Read the full blog post here: sclerodermavictoria.com.au/scleroderma-an…

#OccupationalScleroderma

Understanding a disease as complex as scleroderma requires collaboration. 🌐 Learn more about how the CONQUER Registry is transforming research and how you can get involved: bit.ly/3lLriy5 #SRFcure #sclerodermaresearch #scleroderma #CONQUER

srfcure's tweet image. Understanding a disease as complex as scleroderma requires collaboration. 🌐

Learn more about how the CONQUER Registry is transforming research and how you can get involved: bit.ly/3lLriy5

#SRFcure #sclerodermaresearch #scleroderma #CONQUER

Scleroderma 101! What happens when your own body turns against you? Scleroderma is a relentless rare disease that goes far beyond the skin. #Scleroderma #RareDisease #CME @SclerodermaCO


Scleroderma 101! What happens when your own body turns against you? Scleroderma is a relentless rare disease that goes far beyond the skin. #Scleroderma #RareDisease #CME @SclerodermaCO


Join expert rheumatologists from @NorthwesternMed for the Scleroderma Educational Event on October 24. This event will explore the latest developments in #scleroderma research and management from a multidisciplinary perspective. Learn more and register now:…


⭐ Enhance your understanding of #scleroderma with our newly uploaded slide deck and literature highlights. Visit the #SclerodermaForum today to access these free resources: ow.ly/KfY150WYO5E

ScleroForum's tweet image. ⭐ Enhance your understanding of #scleroderma with our newly uploaded slide deck and literature highlights. 

Visit the #SclerodermaForum today to access these free resources: ow.ly/KfY150WYO5E

2024 @RheumatologyUK guideline for management of systemic sclerosis #scleroderma Early diagnosis ▶️History: #Raynaud’s phenomenon ▶️Examination: Puffy fingers ▶️Investigation: ANA, nailfold #capillaroscopy, SSc-specific autoantibodies 👉🏽academic.oup.com/rheumatology/a… via @RheumJnl

DrAiLynTan's tweet image. 2024 @RheumatologyUK guideline for management of systemic sclerosis #scleroderma

Early diagnosis
▶️History: #Raynaud’s phenomenon
▶️Examination: Puffy fingers
▶️Investigation: ANA, nailfold #capillaroscopy, SSc-specific autoantibodies

👉🏽academic.oup.com/rheumatology/a…
via @RheumJnl

🧵1/ 👁 Ever wanted to see autoimmune Microvascular dysfunction in action? Nailfold Videocapillaroscopy (NVC) gives us a live look into systemic vascular health. A powerful, non-invasive window for early diagnosis in CTDs. Let’s walk through what it reveals in #Scleroderma.…

IlliasulK's tweet image. 🧵1/
👁 Ever wanted to see autoimmune Microvascular dysfunction in action?

Nailfold Videocapillaroscopy (NVC) gives us a live look into systemic vascular health. A powerful, non-invasive window for early diagnosis in CTDs.

Let’s walk through what it reveals in #Scleroderma.…

#Scleroderma specific autoantibodies in predicting prognosis/survival ➡️ almost all #ANA positive 📈 Best survival in anticentromere group 📉 Diffuse subtype carries a worse prognosis especially Anti-Scl70, anti-RNA polymerase III & If 🫁 ILD present [AL Herrick]

LastManStand85's tweet image. #Scleroderma specific autoantibodies in predicting prognosis/survival 

➡️ almost all #ANA positive

📈 Best survival in anticentromere group
 
📉 Diffuse subtype carries a worse prognosis especially Anti-Scl70, anti-RNA polymerase III & If 🫁 ILD present 

[AL Herrick]

🧵 Skin Manifestations of Systemic Sclerosis (SSc) The skin is often the first—and most revealing—organ affected. Here’s a layered look at what to watch for 👇 #Rheumatology #Scleroderma #MedTwitter @IhabFathiSulima @Janetbirdope @DrAkhilX @Drkhenaizan @MattersRheum

Rheumat_Aravind's tweet image. 🧵 Skin Manifestations of Systemic Sclerosis (SSc)
The skin is often the first—and most revealing—organ affected. Here’s a layered look at what to watch for 👇
#Rheumatology #Scleroderma #MedTwitter @IhabFathiSulima @Janetbirdope @DrAkhilX @Drkhenaizan @MattersRheum

Hope for people. Living with #scleroderma but ?too many #trials Difficult to recruit! gaps 👇 need to study lcSSc, longer disease duration ?prevention in ⬆️risk #VEDOSS Dr Dinesh Khanna presents LOADs of #trials #FSR2025 @FloridaRheums @RheumNow @sclerodermaUM

Janetbirdope's tweet image. Hope for people. Living with
#scleroderma 

but 
?too many #trials

Difficult to recruit!

gaps
👇
need to study lcSSc, 
longer disease duration 
?prevention in ⬆️risk #VEDOSS

Dr Dinesh Khanna presents LOADs of #trials 

#FSR2025 @FloridaRheums @RheumNow  @sclerodermaUM

The 3rd #Scleroderma_preceptorship_program The journey of enhancing and optimizing the care of #Scleroderma patients in Saudi Arabia continues to show more promise 💐 Big thanks to: Patients, attendees, speakers and chairpersons @ssrsa_org for facilitating @Boehringer

WaleedHafiz786's tweet image. The 3rd #Scleroderma_preceptorship_program 

The journey of enhancing and optimizing the care of #Scleroderma patients in Saudi Arabia continues to show more promise 💐

Big thanks to: 
Patients, attendees, speakers and chairpersons

@ssrsa_org for facilitating 
@Boehringer…
WaleedHafiz786's tweet image. The 3rd #Scleroderma_preceptorship_program 

The journey of enhancing and optimizing the care of #Scleroderma patients in Saudi Arabia continues to show more promise 💐

Big thanks to: 
Patients, attendees, speakers and chairpersons

@ssrsa_org for facilitating 
@Boehringer…
WaleedHafiz786's tweet image. The 3rd #Scleroderma_preceptorship_program 

The journey of enhancing and optimizing the care of #Scleroderma patients in Saudi Arabia continues to show more promise 💐

Big thanks to: 
Patients, attendees, speakers and chairpersons

@ssrsa_org for facilitating 
@Boehringer…
WaleedHafiz786's tweet image. The 3rd #Scleroderma_preceptorship_program 

The journey of enhancing and optimizing the care of #Scleroderma patients in Saudi Arabia continues to show more promise 💐

Big thanks to: 
Patients, attendees, speakers and chairpersons

@ssrsa_org for facilitating 
@Boehringer…

Great @SmidtHeart #research seminar by X. Mike Jones. Lead #ncRNA compound TY1 reverses the key manifestations of #scleroderma in two complementary mouse models! It even works orally. Next goal: first-in-human studies in #systemicsclerosis patients! @CedarsSinaiMed

MarbanLab's tweet image. Great @SmidtHeart #research seminar by X. Mike Jones. Lead #ncRNA compound TY1 reverses the key manifestations of #scleroderma in two complementary mouse models! It even works orally. Next goal: first-in-human studies in #systemicsclerosis patients!
@CedarsSinaiMed

Bang-up @MarbanLab mtg presentation by @nih_nhlbi #T32 fellow @XMichaelJonesMD gives new hope for #scleroderma. In two #mouse models and human #SSc #macrophages (🙏@fboinMD), #ncRNA drug TY1 attenuates #DNAdamage and reverses disease. 👍. Thanks Mike for your great work!…

MarbanLab's tweet image. Bang-up @MarbanLab mtg presentation by @nih_nhlbi #T32 fellow @XMichaelJonesMD gives new hope for #scleroderma. In two #mouse models and human #SSc #macrophages (🙏@fboinMD), #ncRNA drug TY1 attenuates #DNAdamage and reverses disease. 👍. Thanks Mike for your great work!…
MarbanLab's tweet image. Bang-up @MarbanLab mtg presentation by @nih_nhlbi #T32 fellow @XMichaelJonesMD gives new hope for #scleroderma. In two #mouse models and human #SSc #macrophages (🙏@fboinMD), #ncRNA drug TY1 attenuates #DNAdamage and reverses disease. 👍. Thanks Mike for your great work!…
MarbanLab's tweet image. Bang-up @MarbanLab mtg presentation by @nih_nhlbi #T32 fellow @XMichaelJonesMD gives new hope for #scleroderma. In two #mouse models and human #SSc #macrophages (🙏@fboinMD), #ncRNA drug TY1 attenuates #DNAdamage and reverses disease. 👍. Thanks Mike for your great work!…
MarbanLab's tweet image. Bang-up @MarbanLab mtg presentation by @nih_nhlbi #T32 fellow @XMichaelJonesMD gives new hope for #scleroderma. In two #mouse models and human #SSc #macrophages (🙏@fboinMD), #ncRNA drug TY1 attenuates #DNAdamage and reverses disease. 👍. Thanks Mike for your great work!…

Hey everyone! Today is #WorldSclerodermaDay I’m raising awareness about this debilitating disease! I’m in my 4th year. Don’t give up hope! We will find a cure. I’m happy to be thriving. Thanks for the love! ❤️🙏🏼#scleroderma

ClaireDeVille3's tweet image. Hey everyone! Today is #WorldSclerodermaDay I’m raising awareness about this debilitating disease! I’m in my 4th year. Don’t give up hope! We will find a cure. I’m happy to be thriving. Thanks for the love! ❤️🙏🏼#scleroderma

#Scleroderma mimics From Textbook Scleroderma From Pathogenesis to Comprehensive management. Chapter 11 (Hummers et Tyndall) 2024 👇 #Rheumatology #MedTwitter

LastManStand85's tweet image. #Scleroderma mimics 
From Textbook Scleroderma From Pathogenesis to Comprehensive management. Chapter 11 (Hummers et Tyndall) 2024 👇 
#Rheumatology #MedTwitter

#Scleroderma organ specific associated antibodies. #systemicsclerosis & Antibodies associated w/overlap SSc Extracted from Textbook Scleroderma From Pathogenesis to Comprehensive management 2024 #Rheumatology #MedTwitter 👇

LastManStand85's tweet image. #Scleroderma organ specific associated antibodies. #systemicsclerosis & Antibodies associated w/overlap SSc 

Extracted from Textbook Scleroderma From Pathogenesis to Comprehensive management 2024 

#Rheumatology #MedTwitter 

👇
LastManStand85's tweet image. #Scleroderma organ specific associated antibodies. #systemicsclerosis & Antibodies associated w/overlap SSc 

Extracted from Textbook Scleroderma From Pathogenesis to Comprehensive management 2024 

#Rheumatology #MedTwitter 

👇

2 years ago,I was invited onto @BBCSheffield Paulette's show to talk about my #scleroderma I've kindly been invited back on to talk about allsorts this Wednesday morning! Wish me luck !!

sclerodermasara's tweet image. 2 years ago,I was invited onto @BBCSheffield Paulette's show to talk about my #scleroderma 
I've kindly been invited back on to talk about allsorts this Wednesday morning! Wish me luck !!

My dear son in law. Waiting for #lungtransplant #scleroderma #VGH grateful to donors grateful to doctors

karen_kelowna's tweet image. My dear son in law. Waiting for #lungtransplant #scleroderma
#VGH grateful to donors grateful to doctors

Thank you to Dr. Dinesh Khanna @sclerodermaUM @umichmedicine for an insightful Med #GrandRounds @nyugrossman today on recent studies & advances in our understanding of systemic scleroderma - including risk of #Raynaud’sPhenomonen progressing to systemic #scleroderma @NIH_NIAMS

NYULH_DeptofMed's tweet image. Thank you to Dr. Dinesh Khanna @sclerodermaUM  @umichmedicine for an insightful Med #GrandRounds @nyugrossman today on recent studies & advances in our understanding of systemic scleroderma - including risk of #Raynaud’sPhenomonen progressing to systemic #scleroderma @NIH_NIAMS
NYULH_DeptofMed's tweet image. Thank you to Dr. Dinesh Khanna @sclerodermaUM  @umichmedicine for an insightful Med #GrandRounds @nyugrossman today on recent studies & advances in our understanding of systemic scleroderma - including risk of #Raynaud’sPhenomonen progressing to systemic #scleroderma @NIH_NIAMS

Loading...

Something went wrong.


Something went wrong.


United States Trends